NewLimit is hosting a dinner in Boston on September 24 to connect with talented scientists and engineers.
Published
Signal category
Presence & Recognition
Quote
“NewLimit is hosting a dinner in Boston on September 24 to connect with talented scientists & engineers.”
— Jacob Kimmel|NewLimit team
Company
NewLimit
NewLimit is a biotechnology company working to extend human healthspan by developing epigenetic reprogramming therapies.
- Industry
- Biotechnology Research
- Location
- South San Francisco, US
- Company size
- 63 employees
NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale. All correspondence from NewLimit will come from an @NewLimit.com email address.
Founded 2022